Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes

Tara T.M. Lee, M.B., B.S., Corinne Collett, B.Sc., Simon Bergford, M.S., Sara Hartnell, B.Sc., Eleanor M. Scott, M.D., Robert S. Lindsay, Ph.D., Katharine F. Hunt, M.D., David R. McCance, M.D., Katharine Barnard-Kelly, Ph.D., David Rankin, Ph.D., Julia Lawton, Ph.D., Rebecca M. Reynolds, Ph.D., Emma Flanagan, Ph.D., Matthew Hammond, M.Sc., Lee Shepstone, Ph.D., Malgorzata E. Wilinska, Ph.D., Judy Sibayan, M.P.H., Craig Kollman, Ph.D., Roy Beck, Ph.D., Roman Hovorka, Ph.D., and Helen R. Murphy, M.D. for the AiDAPT Collaborative Group.

Link to Paper

Robert Lindsay Paper

Summary

Researchers at SCMH were delighted to contribute as a centre for the AiDAPT trial of automated insulin delivery in pregnancy.  The landmark multicentre RCT, led out of University of East Anglia and funded by NIHR,  was published in the New England Journal on 5th October.  It demonstrated improved glycaemic control during pregnancy using the CamAPS hybrid closed loop and had recruited from 8 UK centres including Glasgow. 

The study  is expected to be instrumental in increasing the availability of this technology to people with type 1 diabetes during pregnancy will be influential in clinical guidelines.


First published: 16 October 2023